Literature DB >> 12541147

Upregulation of FGF-2 in reactive spinal cord astrocytes following unilateral lumbar spinal nerve ligation.

Francesca Madiai1, Syed-Rehan A Hussain, Virginia M Goettl, Richard W Burry, Robert L Stephens, Kevin V Hackshaw.   

Abstract

Spinal nerve ligation results in dramatic changes in spinal cord primary C-afferent fibers, which include atrophy with an accompanied decrease in calcitonin-gene-related peptide (CGRP). These changes parallel the activation of astrocytes, which have been implicated in the ensuing neuropathic pain states. As part of an effort to elucidate the role of the downstream effectors of astrocyte reactivity in the context of allodynia, the expression of fibroblast growth factor-2 (FGF-2) was examined following tight ligation of L5 and L6 spinal nerves. FGF-2 is a pleiotropic cytokine that is synthesized and secreted by neurons and astrocytes. FGF-2 immunoreactivity was increased in ipsilateral dorsal horn reactive astrocytes at 1 and 3 weeks following nerve ligation. Semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR) of laser-captured dorsal spinal cord sections revealed an increase in FGF-2 mRNA in the dorsal horn ipsilateral to nerve injury compared to contralateral and SHAM. Furthermore, an increase in FGF-2 mRNA in ispilateral dorsal root ganglia (DRG) was seen by in situ hybridization. These results demonstrate that, in response to ligation-induced injury of sensory neurons, FGF-2 is upregulated in both DRG neurons and in spinal cord astrocytes, suggesting neurotrophic functions of this growth factor following peripheral nerve lesion and possibly in astrocyte-related maintenance of pain states.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12541147     DOI: 10.1007/s00221-002-1286-3

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  16 in total

1.  Anti-fibroblast growth factor-2 antibodies attenuate mechanical allodynia in a rat model of neuropathic pain.

Authors:  Francesca Madiai; Virginia M Goettl; Syed-Rehan Hussain; Alec R Clairmont; Robert L Stephens; Kevin V Hackshaw
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 2.  Chemical priming for spinal cord injury: a review of the literature part II-potential therapeutics.

Authors:  Martin M Mortazavi; Ketan Verma; Aman Deep; Fatemeh B Esfahani; Patrick R Pritchard; R Shane Tubbs; Nicholas Theodore
Journal:  Childs Nerv Syst       Date:  2010-12-21       Impact factor: 1.475

Review 3.  Targeting astrocyte signaling for chronic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

4.  Involvement of microglia and interleukin-18 in the induction of long-term potentiation of spinal nociceptive responses induced by tetanic sciatic stimulation.

Authors:  Yu-Xia Chu; Yu-Qiu Zhang; Zhi-Qi Zhao
Journal:  Neurosci Bull       Date:  2012-02       Impact factor: 5.203

5.  Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway.

Authors:  Ru-Rong Ji; Yasuhiko Kawasaki; Zhi-Ye Zhuang; Yeong-Ray Wen; Isabelle Decosterd
Journal:  Neuron Glia Biol       Date:  2006-11

6.  Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions.

Authors:  Miki Furusho; Aude J Roulois; Robin J M Franklin; Rashmi Bansal
Journal:  Glia       Date:  2015-04-22       Impact factor: 7.452

Review 7.  Activation of JNK pathway in persistent pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Neurosci Lett       Date:  2008-03-13       Impact factor: 3.046

8.  Fgf-2 in astroglial cells during vertebrate spinal cord recovery.

Authors:  Gehan H Fahmy; Marie Z Moftah
Journal:  Front Cell Neurosci       Date:  2010-11-04       Impact factor: 5.505

Review 9.  Emerging targets in neuroinflammation-driven chronic pain.

Authors:  Ru-Rong Ji; Zhen-Zhong Xu; Yong-Jing Gao
Journal:  Nat Rev Drug Discov       Date:  2014-06-20       Impact factor: 84.694

Review 10.  MAP kinase and pain.

Authors:  Ru-Rong Ji; Robert W Gereau; Marzia Malcangio; Gary R Strichartz
Journal:  Brain Res Rev       Date:  2008-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.